SAR Development of Lysine-Based Irreversible Inhibitors of Transglutaminase 2 for Huntington's Disease

Por Wityak, John, Prime, Michael E., Brookfield, Frederick A., Courtney, Stephen M., Erfan, Sayeh, Johnsen, Siw, Johnson, Peter D., Li, Marie, Marston, Richard W., Reed, Laura, Vaidya, Darshan, Schaertl, Sabine, Pedret-Dunn, Anna, Beconi, Maria, Macdonald, Douglas, Muñoz-Sanjuan, Ignacio, Dominguez, Celia
Publicado em 2012

Irreversible 4-Aminopiperidine Transglutaminase 2 Inhibitors for Huntington's Disease

Por Prime, Michael E., Brookfield, Frederick A., Courtney, Stephen M., Gaines, Simon, Marston, Richard W., Ichihara, Osamu, Li, Marie, Vaidya, Darshan, Williams, Helen, Pedret-Dunn, Anna, Reed, Laura, Schaertl, Sabine, Toledo-Sherman, Leticia, Beconi, Maria, Macdonald, Douglas, Muñoz-Sanjuan, Ignacio, Dominguez, Celia, Wityak, John
Publicado em 2012